| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |